The 21-amino-acid peptide ET-1 (endothelin-1) regulates a diverse array of physiological processes, including vasoconstriction, angiogenesis, nociception and cell proliferation. Most of the effects of ET-1 are associated with an increase in intracellular calcium concentration. The calcium influx and mobilization pathways activated by ET-1, however, vary immensely. The present review begins with the basics of calcium signalling and investigates the different ways intracellular calcium concentration can increase in response to a stimulus. The focus then shifts to ET-1, and discusses how ET receptors mobilize calcium. We also examine how disease alters calcium-dependent responses to ET-1 by discussing changes to ET-1-mediated calcium signalling in hypertension, as there is significant interest in the role of ET-1 in this important disease. A list of unanswered questions regarding ET-mediated calcium signals are also presented, as well as perspectives for future research of calcium mobilization by ET-1.
INTRODUCTION
ET (endothelin)-1 is a 21-amino-acid peptide, originally characterized as an endothelium-derived constricting factor in the vasculature [1, 2] . ET-1 also affects a host of non-vascular tissues, including brain, kidney, intestine and adrenal gland [3] . Further experimentation discovered two GPCRs (G-protein-coupled receptors) to which ET-1 binds: the ET A and ET B receptors. Physiological responses to ET-1 can be attributed to ET A receptors, ET B receptors or both. ET-1 is not solely a vasoconstrictor as it also stimulates angiogenesis, induces astrocyte proliferation, activates nociceptive neurons, constricts bronchi and stimulates the production of several inflammatory mediators in neutrophils and macrophages [4] [5] [6] [7] . Dysfunction or dysregulation in the ET system is present in chronic pain, acute renal failure, asthma, colorectal cancer and stroke, but dysfunction is most apparent in vascular diseases such as hypertension [8] [9] [10] [11] .
The role of ET-1 in the vasculature extends beyond its vasoconstricting properties. Plasma ET-1 levels are elevated in humans with salt-sensitive essential hypertension, and vascular ET-1 expression is increased in severe hypertension [12] . In types of human hypertension where plasma ET-1 remains steady, vascular tissues from hypertensive humans exhibit exaggerated reactivity to ET-1 [13] . In the DOCA (deoxycorticosterone acetate)-salt model of hypertension, vascular contraction to ET-1 is decreased even though plasma ET-1 concentrations are increased [14] . This implies that the tissue responses to ET-1 are altered due to dysfunctional ET receptor signalling and not concentration-dependent activation of ET-1-mediated pathways [15] .
As the number of biological responses affected by ET-1 grows, one tenet remains unchanged: many, if not most, of the responses to ET-1 are calcium-dependent. Whether ET receptors increase [Ca 2+ ] i (intracellular calcium concentration) by activating extracellular calcium influx or intracellular calcium release depends on the tissue, ET receptor type and the response being measured [16] [17] [18] . These increases in [Ca 2+ ] i can be due to voltage-dependent calcium influx, store-operated calcium entry, voltage-independent calcium influx, release of one of several intracellular calcium stores or any combination therein [19] [20] [21] . The calcium increases in some cells are transient; in others, ET-1 causes a slow and prolonged increase in intracellular calcium. Subtle changes to these calcium currents can cause major alterations in cellular function, ultimately leading to the pathogenesis of disease. As such, the complex mechanisms by which ET-1 can modulate intracellular calcium to alter cellular function remain a novel and intriguing area of investigation, and are the focus of the present review. Although mechanisms common to ET-1-dependent responses in many tissue types and diseases are discussed in the present review, the effects of ET-1 in the vasculature during hypertension are highlighted.
The present review begins with a focus on calcium signalling, regulation of calcium influx and mobilization of calcium from intracellular calcium stores. We then explore how calcium influx and mobilization are activated by ET-1 and how the interactions between calcium and ET-1 are altered during hypertension. Finally, we provide a list of unanswered questions regarding ET-1-mediated calcium signalling and offer our perspectives for future research of calcium mobilization by ET-1.
BASICS OF CALCIUM SIGNALLING
Responses regulated by ET-1 have been associated with increases in [Ca 2+ ] i , either by influx of calcium or release of intracellular calcium stores. [Ca 2+ ] i is tightly regulated by a multitude of ion channels and exchangers that control influx, efflux, sequestration and release of calcium [22] [23] [24] . Table 1 outlines the different types of plasmamembrane calcium channels and the receptors that modulate intracellular calcium release. Included is a description of their characteristics, known pharmacological activators and known pharmacological inhibitors [19, [25] [26] [27] [28] [29] [30] [31] .
Increases in [Ca 2+ ] i can be due to influx only, store release only or a portion of both, and the contribution of each source of calcium varies between receptors. This complex regulatory mechanism exists to control [Ca 2+ ] i because small changes in amplitude, duration and location of calcium influx are sufficient to cause a wide variety of physiological responses [32] . The pathways for calcium influx and calcium store release are multi-faceted and tightly controlled, since small changes in intracellular calcium can be the difference between cell survival and cell death [33] . Before examining how ET-1 can increase [Ca 2+ ] i , we briefly discuss the mechanisms utilized by many GPCRs to increase calcium influx and cause [Ca 2+ ] i release.
Calcium influx
Generally, calcium enters a cell by passing through a calcium channel that opens in response to any number of stimuli. The calcium concentration within a cell is much lower than the calcium concentration in the extracellular fluid (100 nM compared with 2.5 mM respectively) [34] . This calcium concentration gradient allows calcium ions to move through the channels and into a cell by passive diffusion. Membrane depolarization, ligand binding and release of intracellular stores are all capable of causing plasma membrane calcium channels to open [35] . Those that open due to membrane depolarization are VGCCs (voltage-gated calcium channels) and any others are considered VICCs (voltage-independent calcium channels). VICCs can be broken down further into SOCCs (store-operated calcium channels), LGCCs (ligand-gated calcium channels) and NSCCs (nonselective cation channels).
Release of calcium stores
The major store of intracellular calcium is the endoplasmic reticulum or the sarcoplasmic reticulum in muscle cells [23] . Calcium is liberated from SER (sarcoplasmic/endoplasmic reticulum) stores through two calcium channels: IP 3 Rs [IP 3 (inositol 1,4,5-trisphosphate) receptors] and RyRs (ryanodine receptors) [36, 37] . IP 3 is produced when PLC (phospholipase C) hydrolyses PIP 2 (phosphatidylinositol 4,5-bisphosphate), generating both IP 3 and DAG (diacylglycerol) [38] . DAG affects calcium store release indirectly, whereas IP 3 does so directly. DAG activates PKC (protein kinase C), which then can inhibit IP 3 production by PLC [39] . PKC also phosphorylates VGCCs, which alters their function to either inhibit or sustain calcium influx [21] . IP 3 activates IP 3 Rs on the SER membrane, which then open and allow calcium to leave the SER and enter the cytoplasm [40] .
RyRs, when activated by local increases in intracellular calcium, cause additional calcium release from SER stores [41] . As such, RyRs amplify small calcium signals caused by voltage-dependent calcium influx or IP 3 -mediated calcium release [42] . In addition to amplification of calcium signals, RyRs are involved in the termination of calcium influx across the plasma membrane. RyRs are on the SER membrane closest to the plasma membrane, whereby a 'spark' of calcium from RyRs will activate calcium-sensitive potassium channels and close VGCCs as the membrane hyperpolarizes [43] . RyRs serve to amplify calcium signals rapidly, but then to also terminate voltage-dependent calcium influx. 
RELATIONSHIP BETWEEN ET-1 AND CALCIUM
The interdependence between ET-1 and calcium is apparent when examining both the physiological effects of ET receptor activation and ET-1 synthesis. Although multiple cell types synthesize ET-1, the predominant sources of ET-1 are vascular endothelial cells [44] . Molecules that increase endothelial cell [Ca +2 ] i augment expression of ppET-1 (preproET-1) mRNA via a calcium/CaM/CaMK (calcium/calmodulin/calmodulin kinase) pathway [45, 46] . The physiological responses elicited by ET-1 can be both calcium-dependent and calcium-independent [16, 47, 48] . Some examples of calcium-dependent processes regulated by ET-1 are shown in Table 2 . Table 2 also separates ET A -receptor-dependent responses from ET Breceptor responses, and notes the specific calcium sources activated by each receptor. In some responses, ET A receptors regulate calcium store release and ET B receptors regulate calcium influx (e.g. bronchoconstriction). In others, ET A or ET B receptors regulate both calcium influx and store release. No correlation exists between ET receptor subtype and the source of calcium governing the response. Thus calcium influx and mobilization by ET-1 is cell-type-specific with regard to which ET receptor subtypes are involved [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] .
Some of the most-studied effects of ET-1 are those in the vasculature, where ET-1 acts as a potent vasoconstrictor [65] . ET-1-induced increases in [Ca +2 ] i are similar in pattern to those caused by other calciumdependent vasoconstrictors, where calcium increases in two stages. First, there is an initial increase in [Ca +2 ] i from intracellular calcium stores, which is followed by a sustained increase in [Ca +2 ] i due to the influx of calcium from the extracellular space [20] . This pattern of initial release/sustained influx is evident in non-vascular cells as well, whereby ET-1 can induce neutrophil migration, attenuate cGMP formation in astrocytes, stimulate diuresis and natriuresis, and cause vasorelaxation [56, [66] [67] [68] . What differs between cells and tissues are the specific mechanisms that regulate the initial extracellular calcium influx and the sustained intracellular calcium mobilization in response to ET receptor activation.
CYTOPLASMIC CALCIUM CHANGES EVOKED BY ET-1

Voltage-dependent calcium influx
Mechanism
The specific VGCCs implicated in ET-1-induced calcium entry vary, which is not surprising due to the range of responses ET-1 influences (see Figure 1) . L-type, T-type and R-type calcium channels have all been associated with voltage-dependent calcium influx caused by ET-1, and the relative involvement of each channel type depends on the species and cell type being studied [69, 70] . The activation of multiple calcium channels during voltagedependent calcium influx is not unique to ET-1; what is interesting is that ET-1 may regulate VGCCs directly as well as indirectly. The idea that ET-1 can act as a calcium channel opener was proposed as early as 1988, but it is also possible that ET receptor activation alters the voltagegating properties of VGCCs indirectly, to increase calcium influx through them [71, 72] . Several researchers have published compelling evidence against the theory that ET-1 was a direct agonist of L-type VGCCs, instead postulating that ET-1 altered VGCC function through second messengers such as PLC and PKC [73] [74] [75] . 
ET-receptor-dependence
Changes in hypertension
Pharmacological inhibition of voltage-dependent calcium influx is a well-established and often-used treatment for hypertension, as calcium channel blockers (e.g. nifedipine) decrease blood pressure by inhibiting calcium influx and reducing vasoconstriction [80] . These drugs have cardioprotective benefits as well; prolonged treatment with nifedipine not only lowers blood pressure, but it also improves endothelium-dependent vasorelaxation and reduces ET-1-dependent contraction [81] . Another calcium channel blocker, lacidipine, decreases ventricular hypertrophy and ppET-1 expression in spontaneously hypertensive rats [82] . These findings reinforce the importance of calcium mobilization in the vasculature and show that the relationship between ET-1 and calcium is not a one-way street: ET-1 mobilizes calcium, but increases in calcium also augment the synthesis of ET-1. Thus inhibition of voltage-dependent calcium influx decreases the deleterious effects of ET-1 on vascular function during hypertension, while simultaneously decreasing transcription of ET-1 precursors and ultimately reducing ET-1 production.
Voltage-independent calcium influx
Mechanism
Regardless of the type of VGCCs associated with ET-1-induced calcium influx or the direct/indirect activation of VGCCs by ET-1, inhibition of all voltage-dependent calcium channels does not abolish the inward calcium currents caused by ET-1 [83] . In some excitable tissues, VGCCs are not activated in response to ET-1 [84] . Therefore the remaining ET-1-induced calcium influx is through any of several voltage-independent calcium entry pathways (see Figure 1) . As defined previously, VICCs include calcium channels that are activated by a ligand directly (LGCCs), activated by intracellular calcium release (SOCCs) or by indirect activation through Gprotein-dependent signalling pathways (NSCCs) (see Table 1 ). Although no LGCC activated by ET-1 is currently known, pharmacological investigation shows SOCCs and NSCCs are important influx pathways in ET-1-induced smooth muscle contraction, MAPK (mitogen-activated protein kinase) phosphorylation and arachidonic acid release [85] [86] [87] . The relative contribution of SOCCs and NSCCs to ET-1-mediated calcium influx is dependent on the concentrations of ET-1 used. Inhibition of NSCCs or SOCCs by SKF-96365 or LOE-908 respectively, abolished the calcium currents caused by low concentrations of ET-1 ( 0.1 nM) [88] . In the same study, however, calcium currents caused by higher concentrations of ET-1 were only abolished by a combination of SKF-96365 and LOE-908. Since the opening of both SOCCs and NSCCs could be stimulated by the release of intracellular calcium stores, differentiating ET-1-induced extracellular calcium influx from calcium-induced calcium influx has proven difficult [29] .
ET-receptor-dependence
Similar to voltage-dependent calcium entry, voltageindependent calcium entry can be regulated by either ET A receptors or ET B receptors, depending on the cell or tissue type [85] . Neither ET receptor is associated with calcium influx through only one type of VICC in all cell types.
Changes in hypertension
Changes to voltage-independent calcium entry in hypertension are not well described, but calcium influx through VICCs appears to have little affect on systemic blood pressure. Treatment with Ginoside-Rd, a purported VICC inhibitor, did not lower systemic blood pressure in hypertensive rats [89, 90] . In the same experiment, however, VICC inhibition decreased vascular remodelling and ET-1-induced smooth muscle cell proliferation [90] . Thus, although there is little evidence that voltage-independent calcium influx is involved in the pathogenesis of hypertension, both ET-1 and VICCs are implicated in the progression of hypertension-induced vascular hypertrophy.
Release of intracellular calcium stores
Mechanism
ET receptors cause intracellular calcium store release by activating PLC and increasing IP 3 production [20, 91] . Similar to the effects of ET-1 on calcium influx pathways, the calcium released from IP 3 -sensitive stores does not account for the increase in [Ca +2 ] i entirely [21] . Intracellular calcium must also come from other reticular stores (e.g. ryanodine-sensitive stores) or an atypical intracellular calcium store (e.g. mitochondrial stores and lysosomal stores) that ET-1 can mobilize. In peritubular smooth muscle cells and renal afferent arterioles, ET-1 alters cADP ribose production to sensitize ryanodineactivated SER stores [92] [93] [94] . Neither IP 3 -sensitive stores nor atypical calcium stores, however, account for ET-1-induced increases in intracellular calcium entirely, consistently and across cell types.
ET-receptor-dependence
Although many studies confirm that ET-1 causes intracellular calcium release, none provide evidence that ET A and ET B receptors mobilize different intracellular calcium stores. The intracellular calcium stores mobilized by ET-1 depend upon the cell type and not the ET receptor subtype.
Changes in hypertension
Smooth muscle cells from hypertensive rats maintain increased [Ca 2+ ] i after depolarization, which implies that intracellular calcium storage and mobilization are altered during hypertension [95] . However, IP 3 -mediated calcium released by ET-1 stimulation is blunted in DOCA-salt hypertension and unchanged in spontaneously hypertensive rats [96] . Thus, even though basal [Ca 2+ ] i is increased in hypertension, the ability of ET-1 to mobilize calcium directly is impaired.
THE POSSIBILITIES: BEYOND CALCIUM CHANNELS AND RETICULAR STORES
Increases in intracellular calcium caused by ET-1 are due to a mixture of voltage-dependent calcium influx, voltageindependent calcium influx and mobilization of calcium from multiple intracellular stores. These mechanisms vary in their predominance as a calcium source at different times, in different cell types and at different concentrations of ET-1. No calcium source is linked to ET A or ET B receptors with any specificity across multiple cell types or tissues, since either ET receptor can cause calcium influx through identical pathways in different tissues. ET-1-mediated responses utilize a combination of all of these calcium sources and no one source dominates across multiple cell types. Although many of these individual pathways have been investigated, it is still unclear how ET-1 modulates both influx and release of calcium simultaneously, and these mechanisms do not account for all of the calcium that is mobilized in response to ET-1.
Recent exploration into the calcium signalling pathways induced by ET-1 has offered some interesting alternatives to the traditional influx/release pathways attributed to ET-1-induced calcium mobilization. Although these novel findings are not able to integrate and explain the entirety of ET-1-induced calcium mobilization, they present new and different insights into the function of ET-1 and ET receptors, as well as novel mechanisms for maintaining intracellular calcium concentrations.
Calcium extrusion
In addition to calcium influx mechanisms that increase [Ca 2+ ] i , there are calcium efflux mechanisms that lower the concentration of intracellular calcium back to basal levels. Owing to the large inward concentration gradient, calcium efflux requires the use of energy (in the form of ATP) to push calcium out of the cell and back into the extracellular space [34] . If these mechanisms were inhibited by ET-1, the net result would be prolonged elevation of [Ca 2+ ] i due to retention of calcium [97] . Thus inhibition of calcium efflux mechanisms represents another means by which ET-1 can modify [Ca 2+ ] i . ET-1 suppresses plasma-membrane calcium-ATPase function and expression in hepatic sinusoidal endothelial fenestrae, leading to contraction [98] . ET-1 also causes the NCX (sodium/calcium exchanger) in the plasma membrane of ventricular myocytes to operate in reverse mode, whereby NCX becomes a calcium influx pump instead of a calcium efflux pump [99] . Future research is needed to elucidate the physiological effects which can be attributed to prolonged increases in [Ca 2+ ] i by ET-1.
ET-1 signalling in the nucleus
Traditionally, ET receptors are thought to be plasmamembrane receptors, where they can be activated by extracellular ET-1 to initiate a G-protein-dependent intracellular signalling cascade. Recent work by Bkaily et al. [100] shows the presence of ET B receptors and R-type VGCCs in the nuclear membrane (see Figure 1 ). These authors postulate further that internalization of plasma-membrane ET receptors frees ET-1 from the receptor, and this cytosolic ET-1 activates ET B receptors in the nuclear membrane [100] . The activation of nuclear ET B receptors causes an increase in nuclear calcium by opening R-type calcium channels and NCXs on the nuclear membrane, as well as indirect activation of IP 3 Rs and RyRs located in the nucleoplasmic reticulum [101] . The sequestration of calcium within the nucleus may serve as a regulatory element for maintaining calcium homoeostasis within the cell, much like sarcoplasmic reticular or mitochondrial uptake of calcium. It also may regulate the expression of calcium-sensitive genes or act as a protective mechanism to buffer the nucleus against calcium depletion or overload [102, 103] . If calcium can enter the nucleus, it is likely that it can leave the nucleus as well. What remains to be seen is whether nuclear ET receptors signal differently than membrane ET receptors, and how intracellular ET-1 can regulate both intranuclear and intracellular calcium mobilization. Understanding of the function of nuclear GPCRs is a work-in-progress. Much of this research has focused on the AT 1 receptor [AngII (angiotensin II) type 1 receptor]. Binding sites for AngII on the nuclei of rat hepatocytes turned out to be AT 1 receptors that regulate ROS (reactive oxygen species) production [104, 105] . Further investigations are required to explain the function of nuclear ET receptors and their role in maintaining calcium homoeostasis.
ET receptor dimerization
GPCRs are capable of forming homodimers (e.g. two β 2 -adrenergic receptors together) and heterodimers (e.g. M 2 muscarinic receptor with an M 3 muscarinic receptor) [106, 107] . Research into GPCR dimerization is increasing as the physiological relevance of GPCR dimers becomes more apparent [108] . HEK (human embryonic kidney)-293 cells transfected with human ET A receptors, human ET B receptors or both ET A and ET B receptors show that these receptors can form both homodimers (ET A /ET A and ET B /ET B ) and heterodimers (ET A /ET B ) [109] . The physiological and pharmacological evidence of ET receptor dimers continues to grow as well, as ET A and ET B receptors interact functionally in human bronchi, saphenous vein and C6 glioma cells [110] [111] [112] [113] [114] . ET receptors have the N-and C-terminal-binding motifs for covalent interaction and can be successfully co-immunoprecipitated from transfected cells [115] . Although co-immunoprecipitation of ET A and ET B receptors from many native tissues has proven difficult, ET receptors have been co-precipitated successfully from rat pulmonary resistance arteries [116] . [117, 118] . Thus the presence of different ET receptor homo-and heterodimers changes the profile of the calcium response. These studies did not examine the mechanisms by which dimers alter calcium signalling, but the fact that dimers can modify calcium signalling is fascinating. Exploring how ET receptor dimers can change calcium influx, alter release of intracellular calcium or decrease calcium extrusion and sequestration is worth further investigation.
PERSPECTIVES
Where do we go from here as we continue to disassemble the mechanisms by which ET-1 increases intracellular calcium? Below are thoughts on this question, where we consider mechanisms that may become relevant to ET-1-dependent calcium signalling as research progresses.
ET receptors on other organelles
The presence of receptors and ion channels on intracellular organelles is not limited to the nucleus, as functional TRPV1 [TRP (transient receptor potential) vanilloid 1] channels were discovered on the endoplasmic reticular membrane of dorsal root ganglion neurons [119] . If ET receptors can be found in the membrane of calcium-storing organelles, such as mitochondria or endoplasmic reticulae, they may mobilize calcium and alter cellular function in new and novel ways. If this were true, such a discovery would change the way we think about both calcium signalling and GPCR function.
Receptor-channel interaction
The ability of ET receptors to alter the activity of other receptors, and vice versa, has already been observed in the kidney, where ET B receptors in the renal proximal tubule can interact with dopamine D 3 receptors (another GPCR) to alter natriuresis [120] . Interactions between different GPCRs can influence the type and function of ion channels associated with them, possibly by recruiting different scaffolding and accessory proteins to form a multimeric signalling complex [121] . For example, TRPC1 (TRP canonical 1) receptors and BK channels can associate in vascular smooth muscle, and blockade of either TRPC1 or BK channels enhances ET-1 contraction of small mesenteric arteries [122] . Understanding whether ET-1 can influence receptor and channel interactions remains relatively unexplored.
THE FUTURE: CALCIUM AND BEYOND
As shown in Figure 1 , the current model of ET-1-dependent calcium mobilization is extremely complex for a single peptide with only two officially recognized receptors [3] . Equally numerous are the tools employed to elucidate the mechanisms, from in vivo experiments and in vitro functional assays to cell culture and cell transfection. As each piece of the puzzle of how ET-1 changes intracellular calcium is put into place, we see that it is part of a larger puzzle that challenges how we think about receptor-dependent calcium signalling mechanisms.
